Abstract
Ablative therapies consist of high intensity focused ultrasound, cryotherapy, radiofrequency ablation, irreversible electroporation and laser. They aim to treat urological cancers effectively while minimising side effects compared to those of radical surgery. However, long-term data on their oncological efficacy is lacking.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Reddy D, Peters M, Shah TT, et al. Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience. Eur Urol. 2022;81(4):407–13.
Valerio M, Cerantola Y, Eggener SE, et al. New and established Technology in Focal Ablation of the prostate: a systematic review. Eur Urol. 2017;71(1):17–34.
Salagierski M, Wojciechowska A, Zając K, et al. The role of ablation and minimally invasive techniques in the Management of Small Renal Masses. Eur Urol Oncol. 2018;1(5):395–402.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mayor, N., Shah, T.T. (2023). Ablative Therapies. In: Tolofari, S., Moon, D., Starmer, B., Payne, S. (eds) Imaging and Technology in Urology . Springer, Cham. https://doi.org/10.1007/978-3-031-26058-2_76
Download citation
DOI: https://doi.org/10.1007/978-3-031-26058-2_76
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-26057-5
Online ISBN: 978-3-031-26058-2
eBook Packages: MedicineMedicine (R0)